Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
SUPPRESSION OF IN-VITRO TYPE-1...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
SUPPRESSION OF IN-VITRO TYPE-17 RESPONSES IN SPA PATIENTS USING SMALL MOLECULE ROR-gamma T INHIBITORS
Bibliographic Details
Main Authors:
De Wit, J
,
Al-Mossawi, M
,
Huhn, M
,
Arancibia, C
,
Powrie, F
,
Bowness, P
Format:
Journal article
Published:
2014
Holdings
Description
Similar Items
Staff View
Similar Items
RORγt inhibitors suppress TH17 responses in inflammatory arthritis and inflammatory bowel disease.
by: de Wit, J, et al.
Published: (2015)
Small molecule inhibitors of RORγt for Th17 regulation in inflammatory and autoimmune diseases
by: Jiuping Zeng, et al.
Published: (2023-06-01)
BROMODOMAIN INHIBITORS REDUCE TH17-TYPE RESPONSES IN SPONDYLOARTHRITIS IN VITRO
by: Hammitzsch, A, et al.
Published: (2014)
Small molecule allosteric inhibitors of RORγt block Th17-dependent inflammation and associated gene expression in vivo.
by: Steven A Saenz, et al.
Published: (2021-01-01)
A ROR1 small molecule inhibitor (KAN0441571C) induced significant apoptosis of ibrutinib‐resistant ROR1+ CLL cells
by: Amineh Ghaderi, et al.
Published: (2021-08-01)